Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of Integrated Proteins Limited approved the unaudited financial results for the quarter and nine months ended December 31, 2025, along with the limited review report from statutory auditors B.B. Gusani & Associates. The auditor issued an unqualified (clean) review report with no material misstatements noted. Revenue from operations for the nine-month period stood at approximately Rs 2,173 lakhs. The company reported a small loss of around Rs 0.59 lakhs in Q3 FY26 (Oct-Dec 2025), though it remained in profit for the cumulative nine-month period. The filing also includes a statement on utilization of funds from a preferential issue of Rs 1,744.88 lakhs raised in January-February 2025, with no deviation from the stated objects (capital expenditure, working capital, and general corporate purposes).
For shareholders, the clean auditor review and consistent use of raised funds in line with stated objectives are positive signs. However, the small quarterly loss in Q3 FY26 and the company's modest scale (revenue under Rs 25 crores for nine months) indicate it remains a very small-cap entity with thin profitability. No major red flags or catalysts from this filing.